Form 8-K - Current report:
SEC Accession No. 0001023024-25-000072
Filing Date
2025-07-23
Accepted
2025-07-23 06:53:00
Documents
14
Period of Report
2025-07-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ani-20250723.htm   iXBRL 8-K 31387
2 EX-99.1 anip-20250723xexx991.htm EX-99.1 40623
6 GRAPHIC a1a.jpg GRAPHIC 5505
  Complete submission text file 0001023024-25-000072.txt   206738

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ani-20250723.xsd EX-101.SCH 1755
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ani-20250723_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ani-20250723_pre.xml EX-101.PRE 12491
16 EXTRACTED XBRL INSTANCE DOCUMENT ani-20250723_htm.xml XML 2690
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 251141586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)